FIELD: biotechnologies.
SUBSTANCE: group of inventions refers to microbiology and biotechnology. Proposed strains Lactobacillus crispatus "ВКМ" B-2727D, Lactobacillus gasseri "ВКМ" B-2728D and Lactobacillus plantarum "ВКМ" B-2731D have antagonistic activity in relation to pathogenic and semi-pathogenic microorganisms. Besides, the invention proposes a consortium based on the above strains for production of a bacterial preparation, a biologically active additive, and direct inoculation for obtaining fermented milk product of functional nutrition.
EFFECT: consortium has higher antagonistic activity against pathogenic and semi-pathogenic microorganisms in relation to individual strains of lactobacilli, use of a consortium will allow enlarging the range of devices intended for prophylaxis and treatment of urogenital infections of females.
4 cl, 1 dwg, 7 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STRAIN Lactobacillus fermentum HAVING BROAD SPECTRUM OF ANTAGONISTIC ACTIVITY AND PROBIOTIC LACTOBACTERIUM CONSORTIUM FOR MANUFACTURING BACTERIAL PREPARATIONS | 2013 |
|
RU2528862C1 |
| Lactobacillus jensenii BACTERIA STRAIN HAVING WIDE SPECTRUM OF ANTAGONIST ACTIVITY AND PROBIOTIC CONSORTIUM OF LACTIC ACID BACILLUS TO PREPARE BACTERIAL FERTILISERS | 2015 |
|
RU2572351C1 |
| CONSORTIUM OF PROBIOTIC STRAINS OF Lactobacillus rhamnosus AND Lactobacillus plantarum FOR PRODUCING BACTERIAL PREPARATION AND DIRECT ADMINISTRATION FERMENT FOR PRODUCING FERMENTED MILK AND FERMENTED BEET JUICE | 2012 |
|
RU2506308C1 |
| PROBIOTIC STRAIN LACTOBACILLUS GASSERI AND ITS COMPOSITION WITH LACTOFERRIN FOR PREVENTION OF DIARRHEA, NERROCESSING ENTERHEROLITE AND SEPISIS CAUSED BY ESCHERICHIA COLI STRAINS IN PREMATURELY BORN CHILDREN | 2016 |
|
RU2641258C1 |
| METHOD FOR CRYOPRESERVATION OF AUTOLOGOUS VAGINAL LACTOBACILLI | 2022 |
|
RU2802074C1 |
| USE OF A SYMBIOTIC CONSORTIUM OF PROBIOTIC LACTOBACILLI STRAINS ISOLATED FROM HUMAN MILK, WHICH HAS A BACTERICIDAL EFFECT ON MASTITIS-INDUCING PATHOGENS, FOR THE MANUFACTURE OF DRUGS FOR THE COMPLEX PREVENTION AND TREATMENT OF LACTATIONAL MASTITIS | 2022 |
|
RU2801119C1 |
| USE OF THIOSULPHATE IN ORDER TO POTENTIATE ANTI-PATHOGEN EFFECT OF LACTOBACILLUS | 2013 |
|
RU2667122C2 |
| STRAIN OF MICROORGANISM LACTOBACILLUS PLANTARUM P4, STRAIN OF MICROORGANISM LACTOBACILLUS BUCHNERI P0 AND PROBIOTIC PREPARATION BASED ON THEREOF FOR CORRECTION OF DYSBACTERIOSIS OF DIFFERENT ETIOLOGY IN HUMANS AND ANIMALS | 2002 |
|
RU2247148C2 |
| Lactobacillus rhamnosus strain, POSSESSING ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY AGAINST PATHOGENIC AND OPPORTUNISTIC VAGINAL MICROFLORA | 2013 |
|
RU2570622C2 |
| LACTOBACILLUS CRISPATUS STRAIN FOR TREATMENT OR PREVENTION OF SEXUAL AND UROGENITAL INFECTIONS, SUCH AS VAGINOSIS AND CANDIDIASIS, AND USE THEREOF | 2013 |
|
RU2661102C2 |
